NDC 68788-8564-06 - METFORMIN HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-8564
- Requested NDC
- 68788-8564-06
- Package NDCs from labels
- 68788-8564-1, 68788-8564-3, 68788-8564-6, 68788-8564-9, 68788-8564-06
- Manufacturer
- Preferred Pharmaceuticals Inc. | Harman Finochem Limited
- Effective date
- 2026-10-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MAGNESIUM STEARATE - Preferred Pharmaceuticals Inc. | Harman Finochem Limited | Preferred Pharmaceuticals Inc. | Harman Finochem Limited | 2026-10-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-8564-1 | METFORMIN HYDROCHLORIDE | 100 in 1 BOTTLE | TABLET | 100 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-8564 | METFORMIN HYDROCHLORIDE TABLET [PREFERRED PHARMACEUTICALS INC.] | 1 | Current NDC, 1 package rows | 20240206_5073c482-952c-400c-afff-64380f133bc8.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-8564-1 | EA - Each | 68788-8564 | 8a5c605b-636c-4a13-a737-0ed0a03516e2 | 1 | 2024-05-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metformin hydrochloride | METFORMIN HYDROCHLORIDE | Ajanta Pharma USA Inc. | 1ed9dde4-339c-486f-a346-dde33a5e493f | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Lupin Pharmaceuticals, Inc. | 1200ea71-8a9e-4e49-bb77-7d9fe0d84ae7 | 2026-09-07 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPS | POVIDONE, POLYVINYL ALCOHOL SOLUTION | Harrow Eye, LLC | 049e9cc9-0663-53bc-e063-6294a90a2c4f | 2026-09-04 | Warnings | FZ989GH94E |
| Metformin hydrochloride | METFORMIN HYDROCHLORIDE | Ajanta Pharma USA Inc. | 6d9179a8-9579-4804-a4c7-633f37aef1ee | 2026-09-04 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Granules India Ltd | 73197cb5-3e23-4ac0-b189-f9bc848bce66 | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | b6d7edc9-93d6-4480-906d-55c18d053600 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | ANDA213320 861007 786Z46389E |
| Dapagliflozin and Metformin hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Aurobindo Pharma Limited | 513bdf9f-774c-4f7f-935a-54d3885e80a4 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Glumetza | METFORMIN HYDROCHLORIDE | Santarus, Inc. | fb832474-88d9-4e29-95cd-fbc446944cc4 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Pioglitazone Hydrochloride and Metformin Hydrochloride | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | Aurobindo Pharma Limited | 1fa2703e-fb73-44d5-aaa2-b12b1090d42c | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Proficient Rx LP | d8bd1779-d1c4-4dde-816d-ea72b37bb5cd | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | ANDA213320 861007 786Z46389E |
| Pioglitazone HCL and Metformin HCL | PIOGLITAZONE HCL AND METFORMIN HCL | Torrent Pharmaceuticals Limited | 237d8fa2-633c-4c29-84d3-f1b413610dc3 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 64f5b140-7ad8-4c07-bbfc-ae4618afa850 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | ANDA213320 861007 786Z46389E |
| Sitagliptin and Metformin Hydrochloride | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Sandoz Inc | a0fcdc08-0afc-4912-a126-3efea6bc8c61 | 2026-08-30 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| d Alba UV Essence Waterfull Glow Tint Pink Correcting Face Sunscreen SPF 50 | HOMOSALATE, OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE | Dalba USA Corp | 03e002cf-8526-4e0d-94d7-896d3714d539 | 2026-08-27 | Warnings | 15FIX9V2JP |
| MZANK SUNSCREEN DAILY ULTIMATE PROTECTION SPF50 | SUNSCREEN SPF50 | Guangzhou Meixi Biotechnology Co., Ltd. | 5a0b4bd2-f6ad-35dc-e063-6294a90a8a66 | 2026-08-27 | Warnings | 15FIX9V2JP |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ba0379cb-824e-4798-9ff9-99bcd1bea5cb | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 861004 786Z46389E |
| MELAO Hydrating Lightweight Sunscreen | AVOBENZONE,ENSULIZOLE,HOMOSALATE,OCTISALATE,OCTOCRYLENE,TITANIUM DIOXIDE | Guangdong Aimu Biological Technology Co., Ltd | 59eeaea1-d726-99f3-e063-6394a90aeea3 | 2026-08-26 | Warnings | 15FIX9V2JP |
| Q Skin Science | SUNSCREEN | International Cosmeceuticals, Inc | 59e4c3d0-ee4c-2350-e063-6394a90ac9d2 | 2026-08-25 | Warnings | 15FIX9V2JP |
| Synjardy | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| alogliptin and metformin hydrochloride | ALOGLIPTIN AND METFORMIN HYDROCHLORIDE | Padagis Israel Pharmaceuticals Ltd | 14d98490-4f8f-4d2f-a4e9-7a3d7a0199ba | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.